chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. Pertinent medical history and drug reactions/allergies were not reported. On 30-JUL-2013, the patient was vaccinated with an expired dose of VARIVAX (Merck) (lot number 1224AA and expiration date 26-JUL-2013) (dose, frequency and route were not reported). Concomitant therapy was not reported. No adverse event effects reported. Additional information has been requested.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and unknown gender. patient's concurrent conditions and relevant medical history was not reported. On 05-FEB-2015, the patient was vaccinated with LIQUID PEDVAXHIB (lot number: K008878 with unspecified expiration date) (dose, frequency and route unspecified) that had underwent temperature excursion (incorrect product storage). Concomitant medications were not reported. No adverse effects (no adverse event) were reported. The outcome of the events was unknown. The causality of the events with LIQUID PEDVAXHIB was not reported. Product quality issue was not involved. This is one of several reports from the same reporter. Additional information has been requested.
Rash, swelling, hive, urticaria, and pain at site of injection.
Took the pills 4 consecutive days erroneously. Flu like symptoms after 4th pill. Body aches, fever, stuffy nose, sore throat.
Pt woke up on 11/24/2009 with a red pin point rash behind both ears, on chest, & on back.  Pt complained of itching.  Pt was given Benadryl, which decreased the itching.  On 11/25/2009, the rash was still present, but the rash no longer itches.
About two hours after the injection, started having palpitations and a mild feeling of anxiety. Then started having numbness on upper lip. The numb feeling persisted for 6-7 hours. Watched carefully for swelling--did not observe swelling of lip(s). Have never had this reaction with a flu shot or other vaccine. Was concerning because have had severe allergic reactions in the past to spider bites, and injectable iron.
Headache, Myalgia, CHILLS Narrative:  Other Relevant History:
Diagnosed with stage 4 chronic kidney disease in May 2022.  No prior history of kidney disease.  Diagnosed with ankolosing spondylitis in September 2022, no prior history of autoimmune arthritis
She got her vaccine, on 5/12/22 she had the normal chills, fever, and then started having a headache on the left side, ear pain and pain in her left jaw. She woke up with no vision in her left eye.  Then it progressed to loss of vision in her right eye, no reading vision.  She ended up going to the ER that same day.  Her left eye vision recovered within an hour, her reading vision is still impaired.  On 5/28/22 she had worsening pain on the left side of her face, headaches requiring a hospital visit, and an overnight stay.  She was seen by a neurologist and placed on medication (Trileptal).  She still has the sensation of pain in the jaw and the ear, and intermittent headaches depending on what situation she is doing.  If she is thinking very hard or stressed the pain is worse.    She had a CT scan and an MRI of her brain, which did not show anything.  The neurologist said that there is potential nerve damage, trigeminal and occipital neuralgia.  She is to FU with him.  She saw the ophthalmologist first and he saw no findings and referred her to the ER, but she had just been to the ER.  The neurologist was from her hospital stay.
Information has been received from a registered nurse and a 28 year old female student who was vaccinated with a first and second dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) on 05/22/2002 and 05/29/2002 left arm respectively. The pt reported conflicting second vaccination date of 05/30/2002. The first vaccination was administered by the pt's primary care physician and the second vaccination was administered at the student health center. The pt reported to the school nurse that on 05/30/2002 she had pain at the injection site (left arm) and it radiated to her elbow region for about one week. The area of injection was bruised in appearance. As of 06/06/2002, the injection site was negative for swelling and pain. Conflicting follow-up info has been received from the RN. The RN reported that the pt was vaccinated SC with the first dose of measles virus vaccine live (+) mumps virus vaccine live (+) rubella virus vaccine live (second generation) (lot #642233/0232M) on 05/22/2002 and the second dose of 05/30/2002 less than 1 month after the first injection. The RN reported that the pt did not experience any systemic adverse effects but had localized bruising and mild tenderness at injection site. Subsequently on 05/30/2002, the pt recovered. Unspecified medical attention was sought. No further info is available.
Redness and itchy, became worse after 48hours, very red about 4 inches in diameter at injection site, continued for approx. 5 days then gradually disappeared. Did not seek medical attention.
Patients daughter called and reported the patient started to feel badly last night with vomiting and diarrhea, she also reported a fever today of 103. MD was called and advised patient go to the hospital to be evaluated. The patient was evaluated at the hospital and has since been discharged to home without further incident.
Patient received PPSV23 on 10/5/2020. She returned to the pharmacy on 10/720 with severe redness and swelling of the arm. Patient reported discomfort (itching, fever, chills) not relieved by OTC medications and stated she may seek medical attention if symptoms do not improve. Pharmacist discussed that some redness, pain, swelling may be normal with this type of vaccine but patient's reaction was pretty significant.
Ct. was to received PPD 0.1cc ID on 8/16/04 instead Ct. received Adult Td 0.5 cc ID to left forearm. CT has not been visually assessed by this staff.
Severe migraine 21+ days; Pressure inside head; Unable to use loud voice or talk aloud for extended periods of time; This is a spontaneous report from a contactable nurse, the patient. A 40-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0179) via intramuscular route of administration in the left arm on 17Aug2021 at 13:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient did not receive any concomitant medications. The patient previously received ceftriaxone sodium (ROCEPHIN), clindamycin (MANUFACTURER UNKNOWN), amoxicillin/clavulanate potassium (AUGMENTIN), epinephrine (MANUFACTURER UNKNOWN), and methylprednisolone sodium succinate (SOLU-MEDROL) and experienced drug allergy. On 17Aug2021 at 13:30, the patient experienced severe migraine for more than 21 days, pressure inside head and was unable to use loud voice or talk aloud for extended periods of time. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. On an unknown date in 2021, the patient underwent computed tomography (CT) scan and the results were unknown. Therapeutic measures were taken as a result of the events and included treatment with unspecified pain relievers. The patient also reported that the pain relievers did not work. The clinical outcome of the events severe migraine 21+ days, pressure inside head and unable to use loud voice or talk aloud for extended periods of time were not resolved at the time of this report.
Patient felt dizzy and nauseas about 5-8mins after shot. Sat her down and elevated her legs and gave her an ice pack for her head and she felt better after 2 minutes.
Pt fainted, post/vax, (time elapsed 5 mins). B/P 60/40, ammonia spirits used, B/P 80/50. At a B/P of 100/70, pt sat up & was dizzy again. Continued same for 45 min., transported to ER by EMS. Dx: Acute vasopressor syncope/ortho-hypotension.
syncope event; Initial information received on 03-Aug-2020 regarding an unsolicited valid serious case received from a consumer/non-healthcare professional.  This case involves three unknown demographic patients who had a syncope event (Syncope) following administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE [MENACTRA].  Medical history, medical treatment, vaccination, concomitant therapy and family history were not provided.  On an unknown date, patients received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE (lot U6596AB and expiry date 24-May-2021) via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date, patients developed a serious syncope event (Syncope) immediately (exact latency not reported) after administration of MENINGOCOCCAL A-C-Y-W135 (D CONJ) VACCINE. This event was assessed as medically significant.  Details of laboratory data was not reported.  Final diagnosis was syncope.   It was not reported if the patient received any corrective treatment.  At the time of this report, outcome of the event was not reported (unknown).; Sender's Comments: This case concerns three unknown demographic patient who had syncope immediately after the vaccination with MENACTRA. The time to onset is compatible with the role of vaccine. However, patients medical history, concomitant medication, condition at time of vaccination and lab data ruling out other etiologies were not reported. Based upon the reported information, the role of the vaccine cannot be assessed.
Start of Cellulitis on Right leg and below groin Still have Cellulitis and under clinic care to this date. Autoimmune flareup (previously reported)
I received a rash; I have mouth sores; I have swelling in my legs; I was tired; Headache; This is a spontaneous report from a contactable consumer (patient). A 46-year-old female patient (non-pregnant) received BNT162B2, first dose via an unspecified route of administration at left arm on 06Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation at age of 46-year-old (non-pregnant). The patient medical history included covid prior vaccination. Concomitant drugs were not reported. The patient had Rash, Mouth sores, swelling in her legs, was tired and headache on 10Apr2021. The events resulted to visit doctors or other Healthcare professional office/ Clinic visit, Emergency room, department or Urgent care and hospitalization for 2 days. The patient received creams as treatment for rash. The patient had Covid test on 27May2021 and Covid test result was negative. Outcome of the events was not recovered. The patient received second dose of bnt162b2 on 26Apr2021 at left arm later.   Information on the lot/batch number has been requested.
Pt. presented to EC with 7-day history of shortness of breath, febrile to 101.7 on 03/30/21
Patient said she lost her hearing last Thursday (1/7/2021) around 6pm. She said she totally could not hear anything at all and she went to the ER at 11pm and stayed till 3am. Her hearing loss happened in her left ear and lasted for 5 days and started to hear sounds since Sunday and recovered. She described it as "there was pressure inside the ear" and she said she also went to her doctor and doctor said she had her hearing back 90% to 96%.
Breakthrough case admission after 3 vaccines  Moderna 1/20/21 Lot# 027L20A;  Moderna 2/17/21 Lot# 027L20A;  Moderna 12/15/21 Lot# 032H21A
Three days following administration of my COVID booster (11/4/21), I began feeling mild pain in my left calf. Over the course of the next 10 days, the pain began to worsen and got to the point where I could no longer stand on the leg. On the morning of 11/14/21 I went to the local Medical Center Emergency Room for treatment. Following physical examination and ultrasound, I was diagnosed with deep vein thrombosis in my left popliteal vein. I was prescribed Eliquis and told to stay off of my feet as much as possible and am awaiting a follow-up visit with my nephrologist to discuss continued treatment.
pain above kidneys, tiredness, rapid heartbeat, itchiness,  extreme fatigue (felt like it must feel to be drugged), inability to stay awake, fever 102.7; penetrating chills, headache, loss of voice, dizziness, swollen lymph glands, weakness, excessive sleep,
About 24 hours after getting the 1st dose vaccine,  all the joints down the right side hurt tremendously.  All my joints were painful and sore (arms, hips, legs).  I could not bend my leg and it took extreme effort to even get into bed.   I took Advil, Tylenol and Meloxicam to help with the pain and it did not help to alleviate the pain.  On a scale of 1-10, the pain was an 8.  The pain lasted for 1 week.  By 3/27/2021, I felt fine and it just vanished.  I did not seek medical care, just self treat with Advil, Tylenol and meloxicam.
A non-serious spontaneous report of inadvertent administration of expired H1N1 was received from a registered nurse/health professional concerning a seven-year-old male. Neither relevant medical history nor concomitant medications have been reported for this patient. The original expiration date was 08-Apr-2010, which was reassigned to 29-Mar-2010. On 31-Mar-2010, the patient received the second dose of H1N1, Intranasal for an unknown indication. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments were not applicable and the event was considered to be resolved.
Involuntary body jerking, episodic, with onset approx. 14 hours, post vax. Duration of shaking symptoms, 1 second. Occurrence was 1-4 times a minute. Duration of total episodes about 1 1/2-2 hours.
Information has been received from a female patient (now 68 years old) with osteoporosis, asthma, environmental allergies, drug allergy to erythromycin and ketamine, dust allergy and mold allergy and a history of stroke two and a half years ago who in the 1970's was vaccinated with PPV 23 vaccine (manufacturer unknown, reported as a "pneumonia vaccine", lot # not reported). Concomitant therapy included PREVACID, famotidine (MSD), baby aspirin, CELEXA, EVISTA and montelukast sodium (MSD). Subsequently the patient experienced redness and swelling of her arm at the injection site. No treatment was given to the patient. Lab diagnostics studies were not performed. Subsequently, the patient recovered from the adverse events. The patient had sought unspecified medical attention. The patient also reported that she experienced redness and swelling of her arm at the injection site after receiving the "flu vaccine" (on multiple occasions). The last time she received a flu vaccine (in the 1970's) she developed bronchitis and was hospitalized. Additional information has been requested.
This case was reported by a regulatory authority (Ref: 1505331001) and described the occurrence of pressing pain in the cardiac area in a 21 year old female patient receiving Hepatitis B vaccine (Engerix B) injection for prophylaxis. On 02/28/05 the patient received Hepatitis B vaccine (IM) at 1 ml. The same day, after vaccination the patient developed pain in cardiac area, anxiety, sleep disorder, bad feeling and headache. On 03/03/05, the events resolved. This case was assessed as medically serious by GSK. The regulatory related to authority reported that the events were almost certainly related to vaccination with Hepatitis B vaccine. Further information has been requested. (OMIC)
no adverse effect; first dose in MArch 2018, second dose in April 2019; 36 year old male patient received two doses of PROQUAD; This spontaneous report was received from an administrator via a company representative, refers to a 36-year-old male patient. The patient's medical history, concurrent conditions and concomitant medications were unknown. On an unknown date in March 2018, the patient was vaccinated with first dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) (dose, frequency, route of administration, lot# and expiry unknown) for prophylaxis (product administered to patient of inappropriate age). The second dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was administered on April 2019 (inappropriate schedule of product administration). No adverse effects were reported.
Upon injection felt much burning that never had with other flu shots, and seemed to take longer to inject. I was sitting and she was standing. She must have saw my face, cause she said oh the shots burn this year. Site seemed higher than normal. Ice, MD vss, pain med and lost of mobility. Sent to orthopedic surgeon, MRI showed bicep tendonitis. Going to PT 3x/week, with minimal help pain remains and cannot swim free style and other activities I love to do.
Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  No treatment details were provided; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
Fatigue for 7 days.  Fever 1 day. Chills 2 days.  Body aches 5 days.  Headache 5 days. Blurriness in eyes 1 day.  Vomiting 1 day. Bloody nose 2 days. Dehydration 4 days.
This spontaneous report as received from a medical assistant refers to possibly 3 patients of unknown age and gender. On an unknown date in 2016 the patients were vaccinated with a dose of GARDASIL (reported lot# M004116, expiration date 12-OCT-2017, was invalid for GARDASIL and dose of RECOMBIVAX HB (lot# L004754, expiration date 10-NOV-2016; lot# L040458, expiration date 04-FEB-2018) (doses and routes were not reported). The vaccines were exposed to temperature between 32 Fahrenheit (F) and 34F, 10 days in May 2016. Medical assistant did not even known which vaccines were administered. No symptoms were reported. Additional information has been requested.
The differences started out with a sore arm that occurred the same day as my 2nd dose which occurred the next day after my 1st dose. The morning after my 2nd dose I awoke around 8AM to a 102.1 F temperature and then took 2 extra strength Tylenol (500mg) around 8:15 AM. I felt very groggy, tired, and still had the sore arm. I felt hot and cold spells over the next 6 hour time period. I measured my temperature around 12:30 PM and it was 99.5 F, and I later took another dose of 2 Tylenol (500mg) around 2:10 PM. I was still feeling groggy and tired but the hot and cold fluctuations seemed to be abated. Around 9PM I measured my temperature again and it had  risen to 101.5F, so I took a shower then took two 200mg Advil/Ibuprophen and went to bed around 9:45 Pm . I awoke around 1AM that same night (03/25/21) and was sweating profusely in bed but was too tired to get up. I laid back down and went back too sleep. I awoke that morning around 7:50 AM feeling very sore in my muscles but no additional symptoms. My temperature was measured at 98.3F and I felt back to my normal self. No additional symptoms have presented afterwards.
Severe shortness of breath . Tachycardia with  pulse of 167.  Hospitalization & cardio version Itchy rash of left upper arm
No specific side effects other than sore injection site as of 10/18/21.  Patient was supposed to get Moderna as a 2nd dose after the 1st on 07/13/21 but a dose of Pfizer was mistakenly given to the patient on 10/15/21.
could not move his fingers for 2 weeks after the first dose; This is a spontaneous report from a contactable consumer. The consumer reported for a male patient. A male patient of unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: was not reported) via an unspecified route of administration, administered anatomical location not reported on unspecified date as dose 1, single for COVID-19 immunization. The patient medical history was not reported. The patient concomitant medications were not reported. Reporter stated she received both Pfizer COVID-19 vaccines and will not get the booster dose. Reporter stated that looking at how many had reactions and how many people died, Pfizer did not do so well. Reporter reported that after patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: was not reported) via an unspecified route of administration, administered anatomical location not reported on unspecified date as dose 2, single for COVID-19 immunization patient was sick for 3 weeks. Reporter Caller stated a report that had information about the vaccines stating Pfizer and Moderna, showed that Pfizer had the highest number of reactions, lowest number of reported cases and highest numbers of deaths. Reporter stated this is a withheld report. Reporter stated there were 7000 deaths and it is not over yet. Reporter stated her husband will not get the vaccine because he thinks it is poetic garbage. Reporter stated she got the Pfizer COVID-19 vaccine because of the name and she trusted the name. On unspecified date, after the first bnt162b2 vaccine dose patient could not move his fingers for 2 weeks. The outcome of the event was unknown.  No follow-up attempts are possible, information about lot/batch number cannot be obtained. No further information is expected.
Systemic: Dizziness / Lightheadness-Medium, Systemic: Fainting / Unresponsive-Medium, Systemic: Nausea-Medium, Additional Details: Patient received flu and covid vaccines. Patient went to go sit in the waiting area for observation post covid booster. Fainted after 2 minutes of waiting in the waiting area and hit his head. Immediately was conscious after fall and had to lie down on the floor for ten minutes due to nausea. After paramedics assessed the patient and when he felt strong enough to stand, he left the store without going to the emergency room.
Information has been received from a physician concerning an approximately 4 month old male who was vaccinated with a 2 ml oral dose of rotavirus G1 G2 G3 G4 P1 reassortant vaccine live (human bovine). Subsequently the patient experienced gastroenteritis and diarrhea. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided.
March 28, 2021-severe headache, no energy, blood pressure was very high, Lasted about 2 weeks. Had to take FMLA from work. Pain was too bad.
Patient's chronic psoriasis, which had been in remission for at least several months, and for which she reports she was no longer taking any meds.recurred the day after her first dose of Moderna vaccine.  Exam notable for numerous large, silvery, scaling, psoriasiform plaques, including one that covers most of patient's lower back; also right elbow, left antecubital fossa,  and several on upper abdomen, all non-tender, no erythema, no drainage.
At 10am on Thursday February 25, I SUDDENLY experienced the onset of violent chills, shaking so hard I couldn't initially place a thermomenter in my mouth.  Moments later, this was accompanied by throbbing pain in my lower back.  Eventually I was able to take my temperature and I had fever.  My daughter contacted my primry care physician who told us to go the emergency room. By the time we went to hospital, the chills had stopped as well as the lower back pain. I was quarantined (though they knew I had been vaccinated for COVID) until they tested me for COVID, the test came back negative in an hour.  They did a number of tests and I was discharged around 6:00 pm that evening